BIOCRYST PHARMACEUTICALS INC·4

Feb 9, 1:11 PM ET

BENNETT J CLAUDE 4

4 · BIOCRYST PHARMACEUTICALS INC · Filed Feb 9, 2005

Insider Transaction Report

Form 4
Period: 2005-02-07
BENNETT J CLAUDE
DirectorPresident
Transactions
  • Exercise/Conversion

    Common Stock

    2005-02-07$0.87/sh+1,219$1,06119,469 total
  • Exercise/Conversion

    Stock Option

    2005-02-07$3.59/sh636$2,283402,669 total
    Exercise: $3.59From: 2002-12-12Exp: 2012-12-11Common Stock (636 underlying)
  • Exercise/Conversion

    Common Stock

    2005-02-07$1.04/sh+104$10818,250 total
  • Exercise/Conversion

    Common Stock

    2005-02-07$3.59/sh+636$2,28317,387 total
  • Exercise/Conversion

    Common Stock

    2005-02-07$1.18/sh+759$89618,146 total
  • Exercise/Conversion

    Stock Option

    2005-02-07$1.04/sh104$108401,806 total
    Exercise: $1.04From: 2003-12-11Exp: 2013-12-10Common Stock (104 underlying)
  • Exercise/Conversion

    Stock Option

    2005-02-07$0.87/sh1,219$1,061400,587 total
    Exercise: $0.87From: 2003-02-03Exp: 2013-02-03Common Stock (1,219 underlying)
  • Exercise/Conversion

    Stock Option

    2005-02-07$1.18/sh759$896401,910 total
    Exercise: $1.18From: 2003-08-05Exp: 2013-08-04Common Stock (759 underlying)

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT